Effect of Charlson comorbidity index on complications and outcomes
following Percutaneous nephrolithotomy and Retrograde intrarenal surgery
in elderly patients
Abstract
Objectives: In this study, we aimed to compare the outcomes and
complication rates of percutaneous nephrolithotomy (PCNL) and retrograde
intrarenal surgery (RIRS) in geriatric patients according to Charlson
comorbidity index (CCI). Materials and Methods: Between April 2011 and
January 2020, patients who underwent PCNL and RIRS for renal stone
between 10 and 30 mm in geriatric patients were retrospectively
evaluated. All patients’ Pre-surgery comorbidities were recorded and the
CCI was calculated. The two groups’ perioperative values, stone free
rates and complication rates were compared. Postoperative complications
were noted according to the Clavien scoring system. Results: There were
89 and 72 patients in the PCNL and RIRS group, respectively. The median
age was 67 years in both of groups (p=0.192). The stone size were 22.2 ±
3.5 and 19.9 ± 7.1 in the PCNL and RIRS group, respec¬tively ( p =
0.082). CCI scores were similar in both groups (p=0.098). Stone free and
complication rates were significantly higher in PCNL group (p = 0.021, p
= 0.034). Also we found that overall complication and major complication
rates were statistically significant difference with especially Charlson
comorbidity index score ≥2 in PCNL group (p = 0,016, p = 0,029).
According to correlation analysis of intraoperative and postoperative
results with Charlson comorbidity index, there was positive correlation
between total complication with PCNL and RIRS group, respectively (p
< 0,001, p = 0.024). In addition, there was positive
correlation between lenght of hospital stay with PCNL and RIRS group,
respectively (p = 0,007, p < 0,001). Also there was positive
correlation between blood transfusion requirement with PCNL group
(p=0,009). Conclusion: Despite there was higher stone clearence in PCNL,
the complication rates were higher compared to RIRS. So RIRS might be a
safe alternative treatment method to PCNL in older patients with a high
CCI score.